Marked reduction of proteinuria after removal of a growth hormone-producing pituitary adenoma in a patient with focal segmental glomerulosclerosis: a case report and literature review-Reference-Cited by-同舟云学术

Marked reduction of proteinuria after removal of a growth hormone-producing pituitary adenoma in a patient with focal segmental glomerulosclerosis: a case report and literature review

Published:2022-10-06 Issue:2 Volume:12 Page:164-170
ISSN:2192-4449
Container-title:CEN Case Reports
language:en
Short-container-title:CEN Case Rep

Author:

Ishigaki Shizuka,Oe Yuji^ORCID,Omata Kei,Ono Yoshikiyo,Tezuka Yuta,Morimoto Ryo,Watanabe Shun,Nishioka Hiroyasu,Satoh Fumitoshi,Yoshida Mai,Makino Rui,Okamoto Koji,Nagasawa Tasuku,Inoshita Naoko,Yamada Shozo,Sato Hiroshi,Ito Sadayoshi,Miyazaki Mariko

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://link.springer.com/content/pdf/10.1007/s13730-022-00739-6.pdf

Reference25 articles.

1. De Vriese AS, Wetzels JF, Glassock RJ, Sethi S, Fervenza FC. Therapeutic trials in adult FSGS: lessons learned and the road forward. Nat Rev Nephrol. 2021;17:619–30.

2. Rosenberg AZ, Kopp JB. Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2017;12:502–17.

3. D’Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43:368–82.

4. Melmed S. Medical progress: acromegaly. N Engl J Med. 2006;355:2558–73.

5. Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:3933–51.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Kidney Biomarkers, Nephrin and KIM-1, for the Detection of Early Glomerular and Tubular Damage in Patients with Acromegaly: A Case–Control Pilot Study;Diseases;2024-09-11